Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Demand for Rapid Results, Non-invasive Methods and Automated Monitoring Driving the Global POCT Market

Published: Monday, September 30, 2013
Last Updated: Monday, September 30, 2013
Bookmark and Share
Frost & Sullivan finds healthcare infrastructure modernization in developing nations and expanding application scope boosts opportunities for POCT.

Frost & Sullivan is carefully tracking the transforming global point-of-care testing (POCT) market, offering latest information on key opportunities and critical unmet needs by region.

Identifying in vitro diagnostics (IVD) companies likely to strongly emerge in each POCT segment is a vital result. Key changes in policy and regional market trends provide insight into the future of POCT and, more importantly, outline game-changing strategies for market participants to succeed.

The newly released Global Point-of-Care Testing (POCT) Market analysis finds the global market earned $5.32 billion in 2012 and estimates this to reach $9.02 billion in 2019 at a compound annual growth rate of 7.9 percent.

In addition to quick turnaround times and its role in preventive healthcare, the uptake of POCT is fuelled by the capability to easily integrate with emerging healthcare IT enabling higher value.

This analysis is part of the Frost & Sullivan Life Sciences (http://www.lifesciences.frost.com) Growth Partnership Service program. It provides a comprehensive, global analysis of point of care (POC) tests for blood glucose, HbA1C, cholesterol, blood gas and electrolytes, drugs of abuse, infectious diseases, pregnancy, haematology, and urinalysis, among other areas.

The study also details market drivers and restraints; revenue forecasts and major market trends; political, economic, social and technology analysis; as well as a competitive and market share analysis for the total POCT market and each product segment within the United States, Europe, Asia and Australia.

Manufacturers globally continue to focus on areas in which near-patient diagnosis and monitoring can profoundly change therapy decisions, improve outcomes, and lower costs. Market participants are strengthening their R&D focus for the development of highly sensitive biosensors, less expensive optical systems, and non-invasive systems to integrate into POCT instruments for better performance. Microfluidic systems based on the lab-on-chip concept, along with increased biomarker discoveries of equipment, may cause a paradigm shift in the clinical diagnostic industry.

POCT is gaining traction due to increasing incidence and prevalence of lifestyle diseases such as diabetes. POC HbA1C tests are routinely performed for type 1 and 2 diabetes patients and their proven efficacy encourages continued adoption by doctors.

For instance, in most European countries, these tests are included as part of a routine in a comprehensive screening programme to monitor blood sugar level. Doctors and diabetes specialists recommend HbA1C tests once every three months, helping sustain test volumes.

“The slowly but steadily growing trend towards automation in emerging countries is likely to provide future opportunities for market growth as laboratories and hospitals focus on modernization,” said Frost & Sullivan Healthcare Senior Research Analyst Srinivas Sashidhar. “The market will also be propelled by the higher number of new products and increased patient awareness of diagnostics.”

However, the cost per unit of POC tests is higher than that of central laboratory tests. Other cost factors include the impact of reduced turnaround time, the overall cost of care, the workflow on clinical units, the length of patient stay, and costs of all consumables. Since the overall cost of consumables for POCT is higher than the cost of tests performed in an automated laboratory, there will be hesitation in opting for POC tests, in spite of clear advantages such as immediacy and ease-of-use.

To combat this challenge, healthcare providers and third-party payers must be made aware that the additional costs per test at the POC for the rapid evaluation of patients can lower the overall healthcare delivery cost.

“POC test manufacturers may also look to partner with IT vendors to facilitate enhanced POCT data management,” noted Sashidhar. “This will facilitate automated systems for discrete, time-bound or continuous monitoring. It requires no supervision and will automatically cater to critical patients and notify the relevant medical caregiver.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Changing Phase of Biomarkers
Discover the current scenario and changing business models of the biomarkers field.
Monday, April 13, 2015
Companion Diagnostics Benefit from Fewer Regulatory Barriers in Europe
Future revisions to in-vitro diagnostics laws will offset the launch of new tests, in a market expected to soar to $1,295.1 million in 2018.
Thursday, June 26, 2014
Personalized Medicine Drives Uptake of Next-generation Sequencing in Europe
Future of DNA sequencing will shift from a laboratory-based setup to point of care testing in the next 5 years.
Saturday, May 31, 2014
Emerging Technologies Redefine Infectious Disease Diagnostics
The largest opportunities lie in the developing regions of Asia, Africa and Latin America.
Wednesday, April 23, 2014
Live Cell Imaging Revolutionizes Disease Diagnostics and Drug Discovery
Stakeholder collaboration will be crucial to convert these developments into clinically meaningful tests.
Friday, March 21, 2014
Automated Anatomic Pathology Labs Transform Global Tissue Diagnostics Market
Offering attractive procurement strategies will boost adoption of high-end tools.
Thursday, February 06, 2014
Increasing Public Health Awareness Intensifies Global Uptake of Autoimmune Disease Diagnostics
Frost & Sullivan: Hospitals and laboratories look for cost-effective test panels enabling simultaneous autoimmune diseases testing.
Monday, October 14, 2013
Increasing Prevalence of Heart Disease Drives Growth of Cardiac Biomarkers Diagnostics Market
Participants need to focus on product customization, ease-of-use and reliability.
Monday, April 22, 2013
High Degree of Disease Prevalence Sustains Diabetes Diagnostics Market in Europe
Companies can increase profits by offering customized testing solutions with accurate, result-oriented features.
Thursday, November 29, 2012
Analysis for Tomorrow's Clinical Approach to Diagnostics, Therapy, Intervention and Monitoring Solutions
As the diverse areas of healthcare forge ahead into overlapping mechanisms and treatments, so too must medical technologies reform to solve several challenges via streamlined remedies.
Thursday, March 22, 2012
Converging towards Integrated Healthcare: A Frost & Sullivan Think Tank on Megatrends Affecting the Healthcare Industry
A clear separation between Medical Devices, Healthcare Technologies and Life Sciences is increasingly difficult. Yet the convergence of all areas opens the door to a new era, enabling personalisation, targeted medicines, new drug delivery mechanisms, and virtual patient monitoring tools, while allowing a preventative approach to healthcare at the same time.
Friday, October 08, 2010
Theranostics Paves the Way for Personalised Medicine in Europe, Says Frost & Sullivan
Strategic Analysis of the European Markets for Theranostics finds that theranostics plays a crucial role in every step of drug development process.
Tuesday, March 23, 2010
Scientific News
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
The Light of Fireflies for Medical Diagnostics
EPFL scientists have exploited the light of fireflies in a new method that detects biological molecules without the need for complex devices and high costs.
Could a simple saliva test detect Alzheimer's?
Researchers have presented findings suggesting that a simple, non-invasive diagnostic for Alzheimer's could be within reach.
Cheap Diagnostics with a Portable "Paper Machine"
Scientists have developed a cheap, portable system for point of care diagnostics for a range of infectious diseases, genetic conditions and cancer.
New Variant of Streptococcal Bacteria
Scientists have discovered a new variant of streptococcal bacteria that has contributed to a rise in disease cases in the UK over the last 17 years.
New Insights into “Antenna” of Human Cells
Scientists from the University of Leeds have uncovered the most comprehensive list yet of genes implicated in a group of common inherited diseases.
Discordant NIPT Test Results May Reflect Presence of Maternal Cancer
Results published in Journal of the American Medical Association.
Sperm RNA Test May Improve Evaluation of Male Infertility
To help resolve uncertainty—and guide prospective parents to the right fertility treatments—scientists propose the use of a new kind of fertility test. It involves examining sperm RNA by means of next-generation sequencing.
Optical 'Dog's Nose' Developed to Detect Cancer, Other Diseases
Researchers are using optical spectroscopy to develop a quick, non-invasive “breath test” they believe will have the potential to screen for a variety of diseases, including diabetes, infections and cancers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!